| RS1571783742 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinal dystrophy |
| RS1571796718 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1571801514 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS1571801564 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS1571801788 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinal dystrophy |
| RS1571803654 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa, Junctional epidermolysis bullosa |
| RS1571804630 |
LAMB3
|
Health Risk |
Pathogenic |
— |
| RS1571804681 |
LAMB3
|
Health Risk |
Pathogenic |
— |
| RS1571805164 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS1571805235 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1571810782 |
LAMB3
|
Health Risk |
Pathogenic/Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, LAMB3-related disorder |
| RS1571817103 |
MPZ
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1571817146 |
MPZ
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1571817154 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1571817225 |
MPZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, type I |
| RS1571817544 |
MPZ
|
Health Risk |
Likely pathogenic |
— |
| RS1571817911 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease |
| RS1571817966 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease |
| RS1571818007 |
MPZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, Neuropathy |
| RS1571818248 |
MPZ
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, Intellectual disability |
| RS1571818312 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Inborn genetic diseases |
| RS1571818339 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1571818614 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1571818632 |
MPZ
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1571818721 |
MPZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, type I |
| RS1571818775 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease type 1B |
| RS1571818800 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease |
| RS1571818819 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1571818953 |
MPZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, type I |
| RS1571819084 |
MPZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, type I |
| RS1571819182 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1571819324 |
MPZ
|
Health Risk |
Likely pathogenic |
— |
| RS1571819375 |
MPZ
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1571819890 |
MPZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, type I |
| RS1571819906 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1571819946 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease |
| RS1571819964 |
MPZ
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1571819975 |
MPZ
|
Health Risk |
Likely pathogenic |
Dejerine-Sottas disease, Charcot-Marie-Tooth disease type 1B |
| RS1571820049 |
MPZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, Roussy-Lévy syndrome |
| RS1571820067 |
MPZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, type I |
| RS1571820092 |
MPZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, type I |
| RS1571820100 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1571820143 |
MPZ
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1571820161 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease |
| RS1571820186 |
MPZ
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1571820317 |
MPZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 1B |
| RS1571820401 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease |
| RS1571821003 |
TGFB2
|
Health Risk |
Pathogenic |
Loeys-Dietz syndrome 4, Loeys-Dietz syndrome 4 |
| RS1571821161 |
TGFB2
|
Health Risk |
Likely pathogenic |
— |
| RS1571825459 |
VPS45
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital neutropenia-myelofibrosis-nephromegaly syndrome, Congenital neutropenia-myelofibrosis-nephromegaly syndrome |
| RS1571844539 |
ARF1
|
Health Risk |
Likely pathogenic |
Periventricular nodular heterotopia 8, Periventricular nodular heterotopia 8 |
| RS1571845061 |
IARS2
|
Health Risk |
Pathogenic |
Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome, Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome |
| RS1571848166 |
CRB1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 1, Leber congenital amaurosis 1 |
| RS1571848659 |
CRB1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1571848688 |
CRB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS1571848744 |
CRB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis, Retinal dystrophy |
| RS1571848855 |
CRB1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 1, Leber congenital amaurosis 1 |
| RS1571851717 |
SDHC
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 3, Gastrointestinal stromal tumor |
| RS1571863769 |
IARS2
|
Health Risk |
Pathogenic |
Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome, Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome |
| RS1571865049 |
PTPRC
|
Health Risk |
Pathogenic |
Immunodeficiency 105, Immunodeficiency 105 |
| RS1571865562 |
IARS2
|
Health Risk |
Pathogenic |
Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome, Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome |
| RS1571869120 |
SDHC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Gastrointestinal stromal tumor |
| RS1571869304 |
SDHC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Gastrointestinal stromal tumor |
| RS1571876788 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1571878277 |
CRB1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 1, Leber congenital amaurosis 8 |
| RS1571880832 |
PTPRC
|
Health Risk |
Pathogenic |
Immunodeficiency 104, Immunodeficiency 104 |
| RS1571880941 |
PTPRC
|
Health Risk |
Pathogenic |
Immunodeficiency 104, Immunodeficiency 104 |
| RS1571881557 |
SNX27
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1571889991 |
SDHC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1571890344 |
SDHC
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Pheochromocytoma/paraganglioma syndrome 3 |
| RS1571892193 |
ACTA1
|
Health Risk |
Likely pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS1571892196 |
ACTA1
|
Health Risk |
Likely pathogenic |
Actin accumulation myopathy, Alpha-actinopathy |
| RS1571892209 |
ACTA1
|
Health Risk |
Likely pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS1571892703 |
ACTA1
|
Health Risk |
Likely pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS1571892988 |
ACTA1
|
Health Risk |
Likely pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS1571893145 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS1571893319 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS1571893383 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS1571893783 |
ACTA1
|
Health Risk |
Likely pathogenic |
— |
| RS1571893814 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Congenital myopathy |
| RS1571893878 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Alpha-actinopathy |
| RS1571893885 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS1571894217 |
ACTA1
|
Health Risk |
Likely pathogenic |
Actin accumulation myopathy, Alpha-actinopathy |
| RS1571897130 |
CRB1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 8, Leber congenital amaurosis 8 |
| RS1571898957 |
SDHC
|
Health Risk |
Likely pathogenic |
Pheochromocytoma/paraganglioma syndrome 3, Gastrointestinal stromal tumor |
| RS1571899223 |
SDHC
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Pheochromocytoma/paraganglioma syndrome 3 |
| RS1571899229 |
SDHC
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Pheochromocytoma/paraganglioma syndrome 3 |
| RS1571901213 |
TGFB2
|
Health Risk |
Pathogenic |
— |
| RS1571902862 |
TGFB2
|
Health Risk |
Pathogenic |
— |
| RS1571904218 |
TGFB2
|
Health Risk |
Pathogenic |
Loeys-Dietz syndrome 4, Loeys-Dietz syndrome 4 |
| RS1571904338 |
TGFB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Loeys-Dietz syndrome 4, Loeys-Dietz syndrome 4 |
| RS1571907365 |
GJC2
|
Health Risk |
Pathogenic |
Hypomyelinating leukodystrophy 2, Hypomyelinating leukodystrophy 2 |
| RS1571907430 |
GJC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonic disorder, Intellectual disability |
| RS1571908056 |
GJC2
|
Health Risk |
Likely pathogenic |
Hypomyelinating leukodystrophy 2, Hypomyelinating leukodystrophy 2 |
| RS1571908452 |
GJC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia, Hypomyelinating leukodystrophy 2 |
| RS1571918251 |
IBA57
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 74, Multiple mitochondrial dysfunctions syndrome 3 |
| RS1571918954 |
IBA57
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple mitochondrial dysfunctions syndrome 3, Multiple mitochondrial dysfunctions syndrome 3 |
| RS1571928405 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1571929573 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS1571936130 |
USH2A
|
Health Risk |
Pathogenic |
— |